119 related articles for article (PubMed ID: 34624942)
21. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.
Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Sumiyoshi M; Satomi J; Kageji T; Nagahiro S
Stroke; 2012 Feb; 43(2):478-83. PubMed ID: 22076002
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
[TBL] [Abstract][Full Text] [Related]
23. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
[TBL] [Abstract][Full Text] [Related]
25. A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist.
Papaccio F; Bellei B; Ottaviani M; D'Arino A; Truglio M; Caputo S; Cigliana G; Sciuto L; Migliano E; Pacifico A; Iacovelli P; Picardo M
Cells; 2022 Nov; 11(22):. PubMed ID: 36429011
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype.
Mori D; Miyagawa S; Matsuura R; Sougawa N; Fukushima S; Ueno T; Toda K; Kuratani T; Tomita K; Maeda N; Shimomura I; Sawa Y
Cardiovasc Diabetol; 2019 Mar; 18(1):39. PubMed ID: 30902059
[TBL] [Abstract][Full Text] [Related]
27. Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes.
Silva-Abreu M; Espinoza LC; Rodríguez-Lagunas MJ; Fábrega MJ; Espina M; García ML; Calpena AC
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182532
[TBL] [Abstract][Full Text] [Related]
28. PPAR-γ agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats.
Soliman E; Behairy SF; El-Maraghy NN; Elshazly SM
Life Sci; 2019 Dec; 239():117047. PubMed ID: 31730865
[TBL] [Abstract][Full Text] [Related]
29. PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling.
Dana N; Vaseghi G; Haghjooy Javanmard S
J Pharm Pharm Sci; 2019; 22(1):418-423. PubMed ID: 31509504
[TBL] [Abstract][Full Text] [Related]
30. [Activation of PPARγ pathway enhances cellular anti-oxidant capacity to protect long-term cultured primary rat neural cells from apoptosis].
Wang H; Fan J; Chen W; Gao Z; Zhang G; Wu H; Yu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):23-29. PubMed ID: 30692062
[TBL] [Abstract][Full Text] [Related]
31. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
32. Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats.
Velez LM; Abruzzese GA; Heber MF; Ferreira SR; Motta AB
Pharmacol Rep; 2019 Feb; 71(1):96-104. PubMed ID: 30508725
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain.
García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA
BMC Biol; 2013 Aug; 11():88. PubMed ID: 23915000
[TBL] [Abstract][Full Text] [Related]
34. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
[TBL] [Abstract][Full Text] [Related]
35. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
[TBL] [Abstract][Full Text] [Related]
36. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
[TBL] [Abstract][Full Text] [Related]
37. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
38. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma.
Eucker J; Bängeroth K; Zavrski I; Krebbel H; Zang C; Heider U; Jakob C; Elstner E; Possinger K; Sezer O
Anticancer Drugs; 2004 Nov; 15(10):955-60. PubMed ID: 15514564
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
[TBL] [Abstract][Full Text] [Related]
40. Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats.
Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Kurashiki Y; Satomi J; Sata M; Nagahiro S
Transl Stroke Res; 2018 Jun; 9(3):306-316. PubMed ID: 29110250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
